Immunology and Microbiology
Interferon Alfa
63%
STAT1
45%
Cells
36%
Development
18%
Gene
18%
Cutaneous T-Cell Lymphoma Cell Line
18%
Interferon Type I
9%
Mutation
9%
STAT2
9%
Signal Transduction
9%
Reverse Transcription Polymerase Chain Reaction
9%
Binding Affinity
9%
Complex Formation
9%
Biological Activity
9%
Lymphoma Cell
9%
Growth
9%
Interferon Stimulated Gene Factor 3
9%
STAT3
9%
Recombinant Alpha Interferon
9%
Aptitude
9%
Neuroscience
Interferon Alfa
63%
STAT1
45%
Western Blot
36%
Lymphoma
18%
Receptor Binding
18%
Receptor Expression
18%
Gene
18%
Cell Signaling
9%
Interferon
9%
Binding Affinity
9%
Complex Formation
9%
Reverse Transcription Polymerase Chain Reaction
9%
JAK-STAT Signaling Pathway
9%
STAT3
9%
STAT2
9%
Interferon Stimulated Gene Factor 3
9%
Alpha Interferon Receptor
9%
Recombinant Alpha Interferon
9%
INIS
interferon
100%
lymphomas
45%
genes
27%
levels
9%
growth
9%
proteins
9%
stimulation
9%
mutations
9%
defects
9%
receptors
9%
messenger-rna
9%
malignancies
9%
concentration
9%
polymerase chain reaction
9%
therapeutic agents
9%
affinity
9%
biological effects
9%
oas
9%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
63%
Cutaneous T Cell Lymphoma
27%
Interferon
9%
Messenger RNA
9%
Hematologic Malignancy
9%
STAT1 Protein
9%
Recombinant Alpha Interferon
9%
Interferon Stimulated Gene Factor 3
9%
Alpha Interferon Receptor
9%
Medicine and Dentistry
Alpha Interferon Receptor
9%